These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6826099)

  • 1. Absorption of prednisolone in patients with Crohn's disease.
    Shaffer JA; Williams SE; Turnberg LA; Houston JB; Rowland M
    Gut; 1983 Mar; 24(3):182-6. PubMed ID: 6826099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection.
    Olivesi A
    Therapie; 1985; 40(1):5-7. PubMed ID: 4002184
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.
    Tanner AR; Halliday JW; Powell LW
    Digestion; 1981; 21(6):310-5. PubMed ID: 7250552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc absorption in Crohn's disease.
    Sturniolo GC; Molokhia MM; Shields R; Turnberg LA
    Gut; 1980 May; 21(5):387-91. PubMed ID: 7429301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent.
    Rodrigues CA; Nabi EM; Spiliadis C; McIntyre PB; Phongsathorn V; Lennard-Jones JE; Rosen A; Willoughby JM
    Aliment Pharmacol Ther; 1987 Oct; 1(5):391-9. PubMed ID: 2979682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal permeability in patients with Crohn's disease and their first degree relatives.
    Teahon K; Smethurst P; Levi AJ; Menzies IS; Bjarnason I
    Gut; 1992 Mar; 33(3):320-3. PubMed ID: 1568650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
    Azcue M; Rashid M; Griffiths A; Pencharz PB
    Gut; 1997 Aug; 41(2):203-8. PubMed ID: 9301499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
    Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability in Crohn's disease.
    Murphy MS; Eastham EJ; Nelson R; Pearson AD; Laker MF
    Arch Dis Child; 1989 Mar; 64(3):321-5. PubMed ID: 2495775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal intestinal permeability pattern in colonic Crohn's disease. Absorption of low molecular weight polyethylene glycols after oral or colonic load.
    Olaison G; Sjödahl R; Leandersson P; Tagesson C
    Scand J Gastroenterol; 1989 Jun; 24(5):571-6. PubMed ID: 2762756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
    Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
    Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone absorption in acute colitis.
    Elliott PR; Powell-Tuck J; Gillespie PE; Laidlow JM; Lennard-Jones JE; English J; Chakraborty J; Marks V
    Gut; 1980 Jan; 21(1):49-51. PubMed ID: 7364320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Crohn's disease with late intestinal manifestations.
    Ghandour K; Issa M
    Oral Surg Oral Med Oral Pathol; 1991 Nov; 72(5):565-7. PubMed ID: 1745516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid absorption in Crohn's disease. Studies using L-[carboxyl-14C]ascorbic acid.
    Pettit SH; Shaffer JL; Johns CW; Bennett RJ; Irving MH
    Dig Dis Sci; 1989 Apr; 34(4):559-66. PubMed ID: 2702887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease.
    Den Hond E; Hiele M; Peeters M; Ghoos Y; Rutgeerts P
    JPEN J Parenter Enteral Nutr; 1999; 23(1):7-11. PubMed ID: 9888411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid.
    Nishida T; Miwa H; Yamamoto M; Koga T; Yao T
    Gut; 1982 Sep; 23(9):751-7. PubMed ID: 7106622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.